How much revenue does Parnax Lab make?

Parnax Lab reported 1.88 billion INR in revenue for fiscal year 2025, down 0.5% from 1.89 billion INR in fiscal year 2024. In Q3 2026 revenue was 629.42 million INR.

What companies are similar to Parnax Lab?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Medico Remedies Limited (MEDICO.NS), Auro Laboratories Limited (AUROLAB.BO), Gujarat Inject (Kerala) Ltd (GUJINJEC.BO), Concord Drugs Limited (CONCORD.BO).

Parnax Lab Limited (PARNAXLAB.BO) Stock

About Parnax Lab Limited

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic; herbal; and nutraceutical products. It also provides oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme prepara...

At a glance

Parnax Lab reported revenue of 1.88 billion INR for fiscal year 2025, down 0.5% from fiscal year 2024, and net income of 115.19 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 629.42 million INR, up 56.5% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.